J Korean Soc Neonatol.
2010 Nov;17(2):250-253.
A Novel Argininosuccinate Synthetase Gene Mutation in a Korean Family with Type I Citrullinemia
- Affiliations
-
- 1Department of Pediatrics, Daegu Fatima Hospital, Daegu, Korea. neogubugi@yahoo.co.kr
- 2Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Abstract
- Citrullinemia type I is an urea cycle defect caused by mutations in the argininosuccinate synthetase (ASS1) gene. We report a novel argininosuccinate synthetase gene mutation in a Korean family with type I citrullinemia. Metabolic evaluation revealed significant hyperammonemia. Amino acid/acylcarnitine screening using tandem mass spectrometry showed high level of citrulline. Plasma amino acid analysis showed high level of citrulline and the urine organic acid analysis showed makedly increased level of orotic acid. To confirm diagnosis of citrullinemia we did mutation analysis of the ASS1 gene. The patient was found to have mutations of c.689G>C (p.G230A) and c.892G>A (p.E298K), which were new types of argininosuccinate synthetase gene mutation have never been reported in Korea. We report a novel case of argininosuccinate synthetase 1 gene mutation and suggest that the gene study to the family members is necessary to carry out when a patient is diagnosed as citrullinemia.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Successful treatment of a child with citrullinemia
- A Case of Adult Onset Type II Citrullinemia with SLC25A13 Gene Mutation
- A Case of Citrullinemia Presenting with Status Epilepticus
- Anesthetic care for living donor auxiliary partial orthotopic liver transplantation in the treatment of adult-onset type II citrullinemia: A case report
- Auxiliary partial orthotopic liver transplantation for adult onset type II citrullinemia
